Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Barcelona, Spain; Liver Unit, Hospital Clinic i Provincial de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red (CIBEREHD), Barcelona, Spain.
Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Barcelona, Spain; Liver Unit, Hospital Clinic i Provincial de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red (CIBEREHD), Barcelona, Spain; Research Center for ALPD, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
Redox Biol. 2023 May;61:102643. doi: 10.1016/j.redox.2023.102643. Epub 2023 Feb 24.
Cholesterol is a crucial component of membrane bilayers by regulating their structural and functional properties. Cholesterol traffics to different cellular compartments including mitochondria, whose cholesterol content is low compared to other cell membranes. Despite the limited availability of cholesterol in the inner mitochondrial membrane (IMM), the metabolism of cholesterol in the IMM plays important physiological roles, acting as the precursor for the synthesis of steroid hormones and neurosteroids in steroidogenic tissues and specific neurons, respectively, or the synthesis of bile acids through an alternative pathway in the liver. Accumulation of cholesterol in mitochondria above physiological levels has a negative impact on mitochondrial function through several mechanisms, including the limitation of crucial antioxidant defenses, such as the glutathione redox cycle, increased generation of reactive oxygen species and consequent oxidative modification of cardiolipin, and defective assembly of respiratory supercomplexes. These adverse consequences of increased mitochondrial cholesterol trafficking trigger the onset of oxidative stress and cell death, and, ultimately, contribute to the development of diverse diseases, including metabolic liver diseases (i.e. fatty liver disease and liver cancer), as well as lysosomal disorders (i.e. Niemann-Pick type C disease) and neurodegenerative diseases (i.e. Alzheimer's disease). In this review, we summarize the metabolism and regulation of mitochondrial cholesterol and its potential impact on liver and neurodegenerative diseases.
胆固醇是膜双层的重要组成部分,通过调节其结构和功能特性。胆固醇会运输到不同的细胞区室,包括线粒体,与其他细胞膜相比,其胆固醇含量较低。尽管线粒体内膜(IMM)中胆固醇的含量有限,但 IMM 中胆固醇的代谢起着重要的生理作用,分别作为甾体激素和神经甾体在甾体生成组织和特定神经元中合成的前体,或者通过肝脏中的替代途径合成胆汁酸。胆固醇在细胞器中的积累超过生理水平会通过几种机制对线粒体功能产生负面影响,包括关键抗氧化防御的限制,例如谷胱甘肽氧化还原循环、活性氧的产生增加以及随后的心磷脂氧化修饰,以及呼吸超级复合物的组装缺陷。线粒体胆固醇转运增加的这些不利后果会引发氧化应激和细胞死亡,并最终导致多种疾病的发生,包括代谢性肝病(如脂肪肝和肝癌)、溶酶体疾病(如尼曼-匹克 C 病)和神经退行性疾病(如阿尔茨海默病)。在这篇综述中,我们总结了线粒体胆固醇的代谢和调节及其对肝脏和神经退行性疾病的潜在影响。